| Name | Title | Contact Details |
|---|
Westwood Health Care Ctr is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
MedRisk is the leading provider of managed physical medicine for the workers` compensation industry and related market sectors. Unified through a uniquely integrated, US-based support model, we pride ourselves in combining clinical expertise with highly personal service and responsiveness. This focus allows us to offer distinct value to each stakeholder in the workers` comp process – carriers and TPAs, employers, adjusters and case managers, physicians, network providers and the patients themselves. In short, we`re here for you; at MedRisk, you`re never just a number – you`re an individual who deserves a solution tailored to your exact needs. We`re here to help you reach your goals and improve your outcomes – whatever they may be.
At Medcillary, we provide the latest ancillary products and services that benefit patients and healthcare providers to meet and exceed their unique needs. We are passionate about developing innovative, ground-breaking tests, products and tools to enhance patient care, provide value to our clients, and transform information into knowledge and insights. Our goal is to advance the development and delivery of healthcare and consumer products by providing the highest quality testing possible. Mission: Medcillary was founded with two key principles in place: compliance and clinical relevance with a focus on offering superior and innovative healthcare products aligned to meet the needs of the physicians in our communities, while leading the way for business development and operational excellence through honesty and integrity with our strategic partners. Our vision is to be the most successful and respected medical ancillary solution company in the world. Our core values are: - Commitment - Integrity - Transparency - Pursuit of Excellence - Customer Focus - Respect
Pure Power Athletics, Inc. d/b/a Makkar Athletics Group is a Oakville, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Abeona Therapeutics is focused on developing and delivering gene therapy and plasma-based products for severe and life-threatening rare diseases. Abeona’s lead program is an adeno-associated virus (AAV)-based gene therapy for Sanfilippo syndrome (MPS IIIA and IIIB) in collaboration with patient advocate groups, researchers and clinicians. Clinical trials for Sanfilippo types A and B are anticipated to begin in 2015.